About Dzugan Method
Information Center
Specific Medical Conditions
Testimonials & FAQ's
Sections:
Dzugan Press Releases
January, 2009 :: Physiological data and clinical outcomes demonstrate that bioidentical hormones are associated with lower risks, including the risk of breast cancer and cardiovascular disease, and are more efficacious than their synthetic and animal- derived counterparts. Until evidence is found to the contrary, bioidentical hormones remain the preferred method of HRT. Further randomized controlled trials are needed to delineate these differences more clearly.
Source: Postgraduate Medicine, Volume 121, Issue 1, January 2009, ISSN – 0032-5481, e-ISSN – 1941-9260
Author: Kent Holtorf, MD; Holtorf Medical Group, Inc., Torrance, CA | View Full Article
December, 2008 :: Our objective was to determine the relationships between levels of different dietary nutrients intake with circulating endothelial progenitor cells (EPC) and vascular endothelial function in type II diabetic patients. This study demonstrated that daily thiamine intake was positively correlated with the circulating number of EPCs and FMD in patients with type II diabetes, independent of other dietary nutrients intake.
Source: Mol Nutr Food Res. 2008 Dec;52(12):1421-7.
Author: Wong CY, Qiuwaxi J, Chen H, Li SW, Chan HT, Tam S, Shu XO, Lau CP, Kwong YL, Tse HF.
Cardiology Division, Department of Medicine
The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. | View Full Article
October, 2008 :: A long-standing belief is that higher testosterone (T) will increase the risk of prostate cancer (PCa), yet recent studies do not support this view. The fear that higher T will increase PCa growth stems from a theory of T-dependent PCa growth that originated with observations in a special population (castrated men) that is not particularly relevant to T therapy in hypogonadal men. The negative view of T with regard to PCa should be recognized for what it is--guilt by association.
Source: J Sex Med. 2008 Aug;5(8):1834-40. Epub 2008 Jun 10.
Author: Morgentaler A.
Men's Health Boston, Harvard Medical School, Boston, MA 02445, USA. | View Full Article
August, 2008 :: Our results indicate for the first time that vitamin D3 and K1 association is able to modulate in vitro the differentiation towards osteoblastic phenotype of hMSCs derived from fracture sites, thus offering clinicians a promising and low-cost strategy for reparative osteogenesis.
Source: J Biol Regul Homeost Agents. 2008 Jan-Mar;22(1):35-44.
Author: Gigante A, Torcianti M, Boldrini E, Manzotti S, Falcone G, Greco F, Mattioli-Belmonte M.
Clinica Ortopedica, Università Politecnica delle Marche, Ancona, Italy. | View Full Article
April, 2008 :: Age-related macular degeneration (AMD) predicted stroke and cardiovascular events over the long term in persons aged 49-75 years. This may have potential implications for new intravitreal anti-VEGF AMD therapies.
Source: Br J Ophthalmol. 2008 Apr;92(4):509-12. Epub 2008 Feb 29
Author: Tan JS, Wang JJ, Liew G, Rochtchina E, Mitchell P.
Centre for Vision Research, Department of Ophthalmology
University of Sydney, Westmead Hospital, Hawkesbury Rd, Westmead, NSW Australia. | View Full Article
March, 2008 :: We previously found that the risk of invasive breast cancer varied according to the progestagen component of combined postmenopausal hormone therapy (CHT): progesterone, dydrogesterone, or other progestagens. We conducted the present study to assess how these CHTs were associated with histology- and hormone receptor-defined breast cancer. CONCLUSION: The increase in risk of breast cancer observed with the use of CHTs other than estrogen+progesterone and estrogen+dydrogesterone seems to apply preferentially to ER+ carcinomas, especially those ER+/PR-, and to affect both ductal and lobular carcinomas.
Source: J Clin Oncol. 2008 Mar 10;26(8):1260-8.
Author: Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F.
Institut National de la Santé et de la Recherche Médicale, Villejuif Cedex, France. | View Full Article
February, 2008 :: This review is dedicated to the role of age-related acquired androgenic deficit in coronary heart disease (CHD) pathogenesis. The analysis of literature show that decrease of testosterone production in males leads to development of dyslipidemia, coronary atherosclerosis, obesity and to increase of blood trombus potential. Thus, androgen deficit potentiates early CHD development in males.
Source: Klin Med (Mosk). 2008;86(4):4-7.
Author: Kravchenko AIa, Provotorov VM. | View Full Article
January, 2008 :: Large numbers of hormone replacement therapies (HRTs) are available for the treatment of menopausal symptoms. It is still unclear whether some are more deleterious than others regarding breast cancer risk. The goal of this study was to assess and compare the association between different HRTs and breast cancer risk, using data from the French E3N cohort study. Large numbers of hormone replacement therapies (HRTs) are available for the treatment of menopausal symptoms. It is still unclear whether some are more deleterious than others regarding breast cancer risk. The goal of this study was to assess and compare the association between different HRTs and breast cancer risk, using data from the French E3N cohort study.
Source: Breast Cancer Res Treat. 2008 Jan;107(1):103-11. Epub 2007 Feb 27.
Author: Fournier A, Berrino F, Clavel-Chapelon F.
Institut National de la Santé et de la Recherche Médicale, ERI 20, Institut Gustave Roussy, Villejuif, France. | View Full Article
May, 2007 :: This observation is in line with the hypothesis that the hormonal status in females modulates the cardiovascular risk and that circulating endothelial progenitor cells (EPCs) could be involved in this phenomenon.
Source: Clin Res Cardiol. 2007 May;96(5):258-63. Epub 2007 Feb 26.
Author: Bulut D, Albrecht N, Imöhl M, Günesdogan B, Bulut-Streich N, Börgel J, Hanefeld C, Krieg M, Mügge A.
Division of Cardiology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstrasse 56, 44791, Bochum, Germany. | View Full Article
February, 2007 :: A study performed with 77 subjects suggests an inverse correlation between serum DHEAS level and age-related macular degeneration severity scale with a considerably reduced DHEAS level in age-related macular degeneration.
Source: Am J Ophthalmol. 2007 Feb;143(2):212-216. Epub 2006 Nov 13.
Author: Tamer C, Oksuz H, Söğüt S.
Ophthalmology Department
Mustafa Kemal University, Antakya, Turkey. | View Full Article
Page 3 of 4
View Page: 1 2 3 4